Filing Flows › CorMedix (CRMD) › Capital expenditures
CorMedix (CRMD) capital expenditures by quarter
CorMedix's capital expenditures were $561K in Q2 2026 (second quarter 2026), -23% from Q1 2026. Over the last 6 quarters it ranged from $10K (Q1 2025) to $1.7M (Q4 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $561K | -23% | 23× |
| Q1 2026 | $729K | -58% | 73× |
| Q4 2025 | $1.7M | +240% | — |
| Q3 2025 | $506K | 21× | — |
| Q2 2025 | $24K | +140% | — |
| Q1 2025 | $10K | — | — |
Q2 2026 at a glance
CorMedix, Q2 2026: revenue $102M (+156% year over year), operating margin 42.1%, net earnings $26.0M, operating cash flow $86.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is CorMedix's capital expenditures?
CorMedix's capital expenditures were $561K in Q2 2026 (second quarter 2026), -23% from Q1 2026.
How has CorMedix's capital expenditures changed?
Over the last 6 quarters it ranged from $10K (Q1 2025) to $1.7M (Q4 2025).